Bharti Airtel’s (BHARTI) board has approved an INR320b fund raise, which includes a rights issue of INR250b and perpetual bonds with equity credit of INR70b (foreign denominated). Issue price of INR220/share implies an issuance of
Shares of Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shot up 7.5% during trading on Friday . The stock traded as high as $0.90 and last traded at $0.86. 1,753,743 shares traded hands during mid-day trading, an increase of 258% from the average session volume of 489,758 shares. The stock had prev
Russ Kaplan is a money manager and newsletter advisor who focuses on buying value-oriented stocks with a multi-year investment horizon; here’s his top idea for conservative investors over the coming year.
One of the most under appreciated stocks on Wall Street is Apple (APPL). The stock is among the bluest of blue chips.
Apple has a financial rating of A++. On every measure....More>>>
Energy stocks have been beaten up enough this year to make them attractive again. It’s the opposite story for shares of companies that sell discretionary goods to consumers. They’ve been performing well early in 2017, but it might be wise to lighten up on them as future....More>>>
If you are an adult buying a gift for your father next weekend, he may be old, and perhaps very old. Many people in their 50s and 60s still have fathers. Stocks for Dad? Probably conservative ones, and not too expensive.
Verizon (NYSE: VZ) is one of the safest investments among U.S. stocks. It has not done much to make people money on price alone over the last year. Verizon trades at $49,....More>>>
U.S. home prices are on a roll. And as we head into the New Year, I am expecting another record year for home prices in 2018. Today, I am going to reveal the safest, easiest and most profitable way to benefit from this trend.
Fueled by record-low interest rates and housing inventories, home prices in the United States hit another all-time high in 2017.
Dividend growth investing can be a great way to boost your passive income over time. To do it right, though, you have to find stocks that can both grow their dividends faster than inflation and have sustainable free cash flows for the long haul.
Gilead Sciences (NASDAQ:GILD), a blue chip biotech stock, meets both of these critical criteria. Even so, this top biotech is rarely considered purely....More>>>
Oil and gas stocks are on the move on Wednesday thanks to a rebound in crude prices on a smaller-than-expected inventory build.
Source: Riccardo Annandale Via Unsplash
Never mind that U.S. shale production has pushed output to 14-month highs. Or that overall U.S. crude inventories have soared to record levels. A modicum of good news on the supply side was all it took to drive energy....More>>>
Monday was a mixed day on Wall Street, as gains for major benchmarks contrasted with a decline in indexes tracking smaller companies. Many market participants focused on the White House’s support of Chinese mobile device maker ZTE, which lifted several of the biggest stocks of Chinese technology giants that trade on U.S. exchanges. In general, investors seem to be pleased with the health of....More>>>
Editor’s Note: The EPA’s Nov. 30 decision to maintain the ethanol levels required in transportation fuel was a win for renewables. That’s why we’re revisiting Kent’s outlook for biofuel, its place in the new energy balance, and the investment opportunities it’s opening up now…
&l;p&g;&l;img class=&q;size-full wp-image-14049&q; src=&q;http://blogs-images.forbes.com/antoinegara/files/2018/06/0522_strategies-masa-takeda_650x455.jpg?width=960&q; alt=&q;&q; data-height=&q;455&q; data-width=&q;650&q;&g; Masakazu Takeda, PM of the Hennessy Japan Fund, is finding big returns in
Haemonetics Co. (NYSE:HAE) – Equities researchers at William Blair reduced their Q2 2019 earnings estimates for Haemonetics in a research report issued on Tuesday, August 7th. William Blair analyst B. Weinstein now expects that the medical instruments supplier will post earnings per sh
With 43 projects raising $1.2 billion in initial coin offerings since May 1, according to Nick Tomaino's The Control, and with stratospheric returns for so many ICOs -- 82,000% for Ethereum, 56,000% for IOTA, 44,000% for Stratis, 21,000% for Spectrecoin -- it's no surprise that this